Structural and functional profiling of environmental ligands for estrogen receptors

Environmental Health Perspectives

Volumn 122, Issue 12, 2015, Pages 1306-1313

  Delfosse, Vanessa ^a   Grimaldi, Marina ^b,c,d   Cavaillès, Vincent ^b,c,d   Balaguer, Patrick ^b,c,d   Bourguet, William ^a  

^a CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^b INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^c UNIV MONTPELLIER   (France)

^d CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1, 1 DICHLORO 2, 2 BIS (4 CHLOROPHENYL) ETHYLENE; 4 TERT OCTYLPHENOL; 4, 4' ISOPROPYLIDENEDIPHENOL; AFIMOXIFENE; ALPHA ZERANOL; BENZOPHENONE 2; BENZOPHENONE DERIVATIVE; BENZYLBUTYLPHTHALATE; BISPHENOL C; BUTYL PARABEN; CHLORDECONE; ENVIRONMENTAL CHEMICAL; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FERUTININE; HYDROXYPHENYLTRICHLOROETHANE; LUCIFERASE; RALOXIFENE; TAMOXIFEN; TETRACHLOROBISPHENOL A; UNCLASSIFIED DRUG; ENDOCRINE DISRUPTOR; LIGAND; POLLUTANT;

ANISOTROPY; ARTICLE; BINDING AFFINITY; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; CORRELATION ANALYSIS; EC50; ENVIRONMENTAL FACTOR; FLUORESCENCE ANALYSIS; LIGAND BINDING; LUCIFERASE ASSAY; MEASUREMENT ACCURACY; PRIORITY JOURNAL; PROTEIN DATA BANK; PROTEIN INTERACTION; PROTEIN PURIFICATION; RISK ASSESSMENT; STRUCTURE ANALYSIS; ADVERSE EFFECTS; CHEMISTRY; ENVIRONMENTAL EXPOSURE; EVALUATION STUDY; HIGH THROUGHPUT SCREENING; HUMAN; METABOLISM; POLLUTANT; STRUCTURE ACTIVITY RELATION;

ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LIGANDS; RECEPTORS, ESTROGEN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84920451413     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1408453     Document Type: Article

References (32)

1. Bossard C, Busson M, Vindrieux D, Gaudin F, Machelon V, Brigitte M, et al. 2012. Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer. PloS one 7(9):e44787; doi:10.1371/journal.pone.0044787.
2. Bruning JB, Parent AA, Gil G, Zhao M, Nowak J, Pace MC, et al. 2010. Coupling of receptor conformation and ligand orientation determine graded activity. Nat Chem Biol 6(11):837–843.
3. Couse JF, Korach KS. 1999. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20(3):358–417.
4. Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, et al. 1996. Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci USA 93(22):12626–12630.
5. De Coster S, van Larebeke N. 2012. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health 2012:713696; doi:10.1155/2012/713696.
6. Delfosse V, Grimaldi M, Pons JL, Boulahtouf A, le Maire A, Cavailles V, et al. 2012. Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes. Proc Natl Acad Sci USA 109(37):14930–14935.
7. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. 2009. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30(4):293–342.
8. Docquier A, Garcia A, Savatier J, Boulahtouf A, Bonnet S, Bellet V, et al. 2013. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells. Mol Endocrinol 27(9):1429–1441.
9. Grun F, Blumberg B. 2007. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord 8(2):161–171.
10. Janosek J, Hilscherova K, Blaha L, Holoubek I. 2006. Environmental xenobiotics and nuclear receptors— interactions, effects and in vitro assessment. Toxicol In Vitro 20(1):18–37.
11. Kobayashi Y, Kitamoto T, Masuhiro Y, Watanabe M, Kase T, Metzger D, et al. 2000. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor α and β by interacting directly with the N-terminal A/B domains. J Biol Chem 275(21):15645–15651.
12. le Maire A, Grimaldi M, Roecklin D, Dagnino S, Vivat- Hannah V, Balaguer P, et al. 2009. Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors. EMBO Rep 10(4):367–373.
13. Li Y, Luh CJ, Burns KA, Arao Y, Jiang Z, Teng CT, et al. 2013. Endocrine-disrupting chemicals (EDCs): in vitro mechanism of estrogenic activation and differential effects on ER target genes. Environ Health Perspect 121:459–466; doi:10.1289/ehp.1205951.
14. Lindberg MK, Movérare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, et al. 2003. Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a “Ying Yang” relationship between ERα and ERβ in mice. Mol Endocrinol 17(2):203–208.
15. Madak-Erdogan Z, Charn TH, Jiang Y, Liu ET, Katzenellenbogen JA, Katzenellenbogen BS. 2013. Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators. Mol Syst Biol 9:676; doi:10.1038/msb.2013.28.
16. McDonnell DP, Wardell SE. 2010. The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer. Curr Opin Pharmacol 10(6):620–628.
17. McDonnell DP, Wijayaratne A, Chang CY, Norris JD. 2002. Elucidation of the molecular mechanism of action of selective estrogen receptor modulators. Am J Cardiol 90(1A):35F–43F.
18. Métivier R, Penot G, Flouriot G, Pakdel F. 2001. Synergism between ERα transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 α-helical core and for a direct interaction between the N- and C-terminal domains. Mol Endocrinol 15(11):1953–1970.
19. Molina-Molina JM, Escande A, Pillon A, Gomez E, Pakdel F, Cavaillès V, et al. 2008. Profiling of benzophenone derivatives using fish and human estrogen receptor-specific in vitro bioassays. Toxicol Appl Pharmacol 232(3):384–395.
20. Nettles KW, Bruning JB, Gil G, Nowak J, Sharma SK, Hahm JB, et al. 2008. NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nat Chem Biol 4(4):241–247.
21. Nettles KW, Bruning JB, Gil G, O’Neill EE, Nowak J, Guo Y, et al. 2007. Structural plasticity in the oestrogen receptor ligand-binding domain. EMBO Rep 8(6):563–568.
22. Nettles KW, Sun J, Radek JT, Sheng S, Rodriguez AL, Katzenellenbogen JA, et al. 2004. Allosteric control of ligand selectivity between estrogen receptors α and β: implications for other nuclear receptors. Mol Cell 13(3):317–327.
23. Newbold RR, Jefferson WN, Padilla-Banks E. 2009. Prenatal exposure to bisphenol A at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect 117:879–885; doi:10.1289/ehp.0800045.
24. Nilsson S, Gustafsson JA. 2011. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther 89(1):44–55.
25. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. 2004. Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64(1):423–428.
26. Riu A, Grimaldi M, le Maire A, Bey G, Phillips K, Boulahtouf A, et al. 2011. Peroxisome proliferator-activated receptor γ is a target for halogenated analogs of bisphenol A. Environ Health Perspect 119:1227–1232; doi:10.1289/ehp.1003328.
27. Rubin BS, Soto AM. 2009. Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol 304(1–2):55–62
28. Schug TT, Janesick A, Blumberg B, Heindel JJ. 2011. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 127(3–5):204–215.
29. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA. 2004. Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 101(6):1566–1571.
30. Vuorinen A, Odermatt A, Schuster D. 2013. In silico methods in the discovery of endocrine disrupting chemicals. J Steroid Biochem Mol Biol 137:18–26.
31. Weihua Z, Saji S, Makinen S, Cheng G, Jensen EV, Warner M, et al. 2000. Estrogen receptor (ER) β, a modulator of ERα in the uterus. Proc Natl Acad Sci USA 97(11):5936–5941.
32. Wilson VS, Bobseine K, Gray LE Jr. 2004. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. Toxicol Sci 81(1):69–77.